Exciting news out today dealing with the TN Apothe
Post# of 7769
What triggered my question is the statement below from today's PR.
The Company expects to enter sourcing agreements with several more pharmacies throughout the US allowing Scrips to effectively provide prescriptions across a growing geographic area, further increasing our revenues and shareholder value.
By the way, the answer to my question is SCRC. I said it all along that MAP's revenues are limited by the number of pharmacist and staff to fill Rxs. With this agreement I can see overflow being picked up by TN resulting in less "approved" Rxs and more "filled and billed" Rxs. If anyone is questioning Mr. Schneiderman's business savvy - DON'T!